(Q36919710)

17 August 2017

1 reference

title

Regulation of tissue perfusion in mammals by hypoxia-inducible factor 1. (English)

1 reference

17 August 2017

1 reference

1

Gregg L Semenza

1 reference

17 August 2017

publication date

24 August 2007

1 reference

17 August 2017

published in

Experimental Physiology

1 reference

17 August 2017

volume

92

1 reference

17 August 2017

issue

6

1 reference

17 August 2017

page(s)

988-991

1 reference

Hypoxic induction of an HIF-1alpha-dependent bFGF autocrine loop drives angiogenesis in human endothelial cells

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Progenitor cell trafficking is regulated by hypoxic gradients through HIF-1 induction of SDF-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Cardia bifida, defective heart development and abnormal neural crest migration in embryos lacking hypoxia-inducible factor-1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Studies on the activity of the hypoxia-inducible-factor hydroxylases using an oxygen consumption assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Concordant regulation of gene expression by hypoxia and 2-oxoglutarate-dependent dioxygenase inhibition: the role of HIF-1alpha, HIF-2alpha, and other pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Arteriogenesis versus angiogenesis: similarities and differences

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Critical limb ischemia and stem cell research: anchoring hope with informed adverse event reporting

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Proline hydroxylation and gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Cell type-specific regulation of angiogenic growth factor gene expression and induction of angiogenesis in nonischemic tissue by a constitutively active form of hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

FIH-1 is an asparaginyl hydroxylase enzyme that regulates the transcriptional activity of hypoxia-inducible factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Inhibition of hypoxia-inducible factor activity in endothelial cells disrupts embryonic cardiovascular development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part I: angiogenic cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Therapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Abnormal angiogenesis and responses to glucose and oxygen deprivation in mice lacking the protein ARNT.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Transcriptional regulation of vascular endothelial cell responses to hypoxia by HIF-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Hypoxia-inducible factor 1alpha polymorphism and coronary collaterals in patients with ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

HIF-1 alpha is required for solid tumor formation and embryonic vascularization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Multiple organ pathology, metabolic abnormalities and impaired homeostasis of reactive oxygen species in Epas1-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Loss of HIF-1alpha in endothelial cells disrupts a hypoxia-driven VEGF autocrine loop necessary for tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Purification and characterization of hypoxia-inducible factor 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Bone marrow-derived cells do not incorporate into the adult growing vasculature.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2006.036343

Use of a constitutively active hypoxia-inducible factor-1alpha transgene as a therapeutic strategy in no-option critical limb ischemia patients: phase I dose-escalation experience

21 January 2018

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1113/EXPPHYSIOL.2006.036343

Stabilized HIF-1alpha is superior to VEGF for angiogenesis in skeletal muscle via adeno-associated virus gene transfer

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1113/EXPPHYSIOL.2006.036343

Coronary collateral circulation: clinical significance and influence on survival in patients with coronary artery occlusion

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1113/EXPPHYSIOL.2006.036343

Constitutively active HIF-1alpha improves perfusion and arterial remodeling in an endovascular model of limb ischemia

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1113/EXPPHYSIOL.2006.036343

Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1113/EXPPHYSIOL.2006.036343

Hypoxia-inducible factor 1 levels vary exponentially over a physiologically relevant range of O2 tension

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1113/EXPPHYSIOL.2006.036343

The epidemiology of lower extremity amputations in diabetic individuals

1 reference

12 October 2022

https://opencitations.net/index/coci/api/v1/references/10.1113/EXPPHYSIOL.2006.036343

Identifiers

DOI

10.1113/EXPPHYSIOL.2006.036343

1 reference

17 August 2017

1 reference